chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left arm (injection given in left arm) increasingly sore, then sudden onset of faintness, seeing stars, nausea, arms and legs very shaky, hard time breathing, then progressed to arms and legs not able to move, left arm pain increasing to excruciating pain and feeling like large bee sting, then overall shock, chills, left arm then no longer able to move, then I laid down on sofa, daughter covered me with layers of blankets, called Walgreens, but pharmacist gone for evening, daughter then put ice pack on left arm at injection sight and I took 400 mg of ibuprofen.  After approximately 2 hours, felt slightly better, but was completely wiped out, went to bed, next morning was better, but left arm still sore.
Pt recvd vax 20OCT92 & 31OCT92 devel a fever of 103 to 104, h/a, achy & not feeling well;
I tested positive for COVID on 05/12/2022. At first I thought I was having bad allergies, because where I live is know for having bad allergy season. I was doing a lot of coughing and blowing my nose. I went to go to bed and I ache all over and I thought that was weird because I hadn't did anything to be sore. An I didn't think anything about it and then I went to work and I usually stand at my desk and work but I couldn't. By 9AM I got a call from one of my co-workers and she said that she had COVID. So I left work and went to the doctor. My symptoms were severe for the first 3 days. An now I would said that they are mild. I have a cough, head congestion, headache, body aches, fever, fatigue and chills. It has been 16 since days and am still feeling bad. I went back to the doctor on 05/25/2022 and they said that they believe it had turn into bronchitis. They didn't do a COVID test at all.
Reports pain in bones of hand on vax side & H/A 'along outside top of head' lasting 3-4 hr on 4/18. No c/o on 4/19. 4/20 had sore throat "at back of nasal sinuses", + nasal congestion, T max 102F. 4/21 + yellow/green nasal mucus w/ nose blowing. 4/22 Feeling better, temp 99 F.  Cont't to have URI symptoms & dry cough.  Using homeopathic nasal spray Euphorbium w/ some relief.
Admitted with chest pain, known ACS and abnormal stress test.  cardiolgoy consulted and performed LHC.  LHC with  Ischemic cardiomyopathy, patient LIMA to LAD, patient stents, CTO of the RCA.  Recommended aggressive RF modification, tobacco cessation, medical management.  Medically stable for discharge home.  F/u with PCP and cardiology.   * Precordial chest pain NSTEMI - cardiology consult, performed LHC which recommended medical management, no stents placed.  F/u with cardiology as outpatient.   Covid positive 1/22/2022 - no hypoxia.
my stomach was burning on the inside; I was hot and cold with sweats; I was hot and cold with sweats; chills; I would get hot; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old male patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 21Jul2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included disability, sensitization, central nervous system is more sensitive from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously received fist dose of BNT162B2 on an unspecified date for covid-19 immunisation. On an unspecified date caller is a consumer inquiring about additional information regarding the side effects of the Pfizer Covid-19 vaccine. Caller reports after I got the first one, I didn't feel too bad, but after the second one my stomach was burning on the inside and then I was hot and cold with sweats, chills, then I would get hot. Me and my girlfriend got it at the same 21Jul2021, and my girlfriend is going through the same thing. We got at the same time. May be that's why, because I'm disabled, and my central nervous system is more sensitive. I have sensitization which makes me more sensitive. My girlfriend is also feeling like her stomach is burning, but it could be from having to poop all the time. The outcome of the event was unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date in 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dose, dose # and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported.  The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
I went to the hospital on 4-25-19 to have a small piece of metal removed from my nose. It was a fairly quick event, and the doctor recommended I get a tetanus shot.  I said okay, and the nurse came in and gave me the shot. It was placed very high on my arm and Immediately, I knew something was off because it hurt my shoulder so bad. My shoulder hurt very bad for about 3 weeks. I had some limited movement in my arm due to the pain, especially moving it over my head.  After 3 or so weeks, the pain lowered but did not go away. I currently still have a sore shoulder to this day.  I went to my primary care Dr and we talked about the sor shoulder and I will be getting x-rays done to hopefully see what's going on.
Initial information received on 04-Mar-2019 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 65 years old male immuno-compromised patient who received FLUBLOK QIV and still contracted flu this year. The patients past medical history, concomitant medication and family history were not provided. At the time of the event, the patient was immuno-compromised. On unknown date, in October 2018, the patient received a 0.5 mg dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number, expiry date not reported via unknown route in unknown administration site. On unknown date, the patient developed a non-serious an immuno-compromised patient who received FLUBLOK and still contracted flu this year (influenza like illness) with unknown latency following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Lab data was not provided. Final diagnosis was an immuno-compromised patient who received FLUBLOK and still contracted flu this year. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for an immuno-compromised patient who received FLUBLOK and still contracted flu this year. List of documents held by sender - none.
Itching in knuckles; Reddening of knuckles; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in knuckles) and ERYTHEMA (Reddening of knuckles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching in knuckles) and ERYTHEMA (Reddening of knuckles). At the time of the report, PRURITUS (Itching in knuckles) and ERYTHEMA (Reddening of knuckles) outcome was unknown.            No concomitant medications were provided.  Treatment medications include antihistamines.   This case was linked to MOD-2021-073525 (Patient Link).
In April I experienced a fever which was intermittent.  I do not remember the exact days.  The fever stopped. On May  8, 2021 the fever reoccurred. My temperature was 100.9 degrees.  I contacted my internist,physician, , at her office on Monday, May 10th.  I went to her office that afternoon.  She first  tested me for COVID-19 which came back negative.  She then took bloodwork and also sent me for a chest x-ray.  On Tuesday, I received a phone call stating hat my blood work test results had come back positive for a bacterial infection.  She asked that I come to her office on Wednesday morning, May 12th. She performed a physical exam and then ordered CT scans of my pelvis, abdomen and chest.   I was able to receive the scans that same day.  That afternoon I received a phone call stating that the CT scan of my abdomen showed that I was experiencing diverticulitis.    She prescribed an antibiotic Amoxicillin-CLAV for ten days.  The antibiotic stopped my fever. I am still adjusting my diet for diverticulitis.   The CT scan also I had a congenital congenital foramen hernia.
Itching; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PRURITUS (Itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 25-Jan-2021, the patient experienced PRURITUS (Itching). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
"On 2/9/2021 I noticed multiple red lesions on both of legs. They are not itchy or blisters or weeping. Most are round of variable diameter and I also have three purple linear lesions on my right knee."
2 months later / only administered the lyophilized powder mixed with normal saline; Inappropriate dose of vaccine administered; received the 1st dose of adjuvant suspension only / 2 months later / only administered the lyophilized powder mixed with normal saline; received the 1st dose of adjuvant suspension only / 2 months later / only administered the lyophilized powder mixed with normal saline; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In April 2021, the patient received the 1st dose of Shingrix. In June 2021, the patient received the 2nd dose of Shingrix. In April 2021, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. In June 2021, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The medical assistant stated that, the patient received the 1st dose of adjuvant suspension only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The patient went back 2 months later and only received the lyophilized powder mixed with normal saline, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. No adverse events reported by patient. The reporter consented to follow up. This case is one of 9 linked cases, reported by same reporter for different patients (both male and female patients involved).   Follow up information received from sales representative on 25 June 2021: The reporter stated that, the health care professional mixed the adjuvant portion with saline solution and administrated it as a first dose and later reconstituted the powder portion with saline solution as second dose. The event inappropriate preparation of medication for 1st dose updated to wrong solution used in drug reconstitution as stated that the health care professional mixed the adjuvant portion with saline solution. The reporter did not know exact date, patient's involved and outcome.  No further events were reported. The reporter consented to follow up; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR138546:Same reporter US-GLAXOSMITHKLINE-US2021AMR138552:Same reporter US-GLAXOSMITHKLINE-US2021AMR138554:Same reporter US-GLAXOSMITHKLINE-US2021AMR138555:Same reporter US-GLAXOSMITHKLINE-US2021AMR138556:Same reporter US-GLAXOSMITHKLINE-US2021AMR138557:Same reporter US-GLAXOSMITHKLINE-US2021AMR138558:Same reporter US-GLAXOSMITHKLINE-US2021AMR138559:Same reporter US-GLAXOSMITHKLINE-US2021138628:FU1 Delated
Case number PHEH2014US022434, is an initial spontaneous report from a medical assistant received on 06 Nov 2014. This report refers to a 6-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with FLUVIRIN (batch number: 1413901) intramuscularly at a dose of 0.5 ml that was stored at a temperature of 31 F-47 F for two weeks from a multi dose vial on 01 Nov 2014. No adverse event reported.
This case was reported by a nurse via sales rep and described the occurrence of vaccination failure in a patient who received DTaP vaccine. On an unknown date, the patient received DTaP vaccine at an unknown dose. On an unknown date, unknown after receiving DTaP vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), pertussis (serious criteria GSK medically significant) and cough. On an unknown date, the outcome of the vaccination failure, pertussis and cough were unknown. It was unknown if the reporter considered the vaccination failure, pertussis and cough to be related to DTaP vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, in 2014, there was an outbreak of Pertussis in 5 individuals. The reporter stated that they had all been vaccinated. The patient tested positive, but had no symptoms to minimum symptoms with less coughing. When tested the patient's were pertactin lacking. The reporter was not sure which brand of DTap that was provided. This case was considered as the suspected vaccination failure since the details regarding basic immunization schedule, time to onset for the event were not reported. This case is 1 of the 5 cases which was reported by same reporter.
mom called & said PMD told her to call to state pt had an rxn to shot given 7MAR95 & that pt is to get only DT; mom stated pt had t103, cried x 2 days & had diarrhea; pt taken to MD 8MAR95 & MD stated pt had rxn to DTP
Pain and loss of mobility in left arm within first 12 hours and became worse over next 3-4 days.
pain across mid-back & h/a; want to bed @ 630PM & felt ok by next AM;
Platelets fell below 2,000, causing bleeding of mouth, extensive bruising, and bleeding through the skin.
Patient received first dose and developed a rash that was treated with Benadryl.  After receiving second dose, patient was not feeling well and reported her lips tingling and her throat feeling like it was swelling resulting in trouble swallowing.  No issues reported with trouble breathing.   Patient received 50 mg IM Benadryl in right arm and 911 was called.  Patient left store with paramedics
On Monday, he staggered and felt vertigo; He felt looney all day next day; On Friday(2 days after receiving 2nd dose), He felt as if he was falling through the bed in the morning because of vertigo/the following day he still felt vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (On Friday(2 days after receiving 2nd dose), He felt as if he was falling through the bed in the morning because of vertigo/the following day he still felt vertigo), FEELING ABNORMAL (He felt looney all day next day) and GAIT DISTURBANCE (On Monday, he staggered and felt vertigo) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced VERTIGO (On Friday(2 days after receiving 2nd dose), He felt as if he was falling through the bed in the morning because of vertigo/the following day he still felt vertigo). On 28-Aug-2021, the patient experienced FEELING ABNORMAL (He felt looney all day next day). On 30-Aug-2021, the patient experienced GAIT DISTURBANCE (On Monday, he staggered and felt vertigo). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at a dose of unknown and MECLOZINE HYDROCHLORIDE (BONINE) at a dose of Unknown. At the time of the report, VERTIGO (On Friday(2 days after receiving 2nd dose), He felt as if he was falling through the bed in the morning because of vertigo/the following day he still felt vertigo), FEELING ABNORMAL (He felt looney all day next day) and GAIT DISTURBANCE (On Monday, he staggered and felt vertigo) outcome was unknown.            No Concomitant information were reported.
Rash, hives, itching, swollen eyes, bridge of her nose, ear lobes swollen cheeks. Pain, redness, lethargic, loss of appetite.
Gave Immunizations not realizing that IPV was in fact Polio. So the patient got an extra dose. Mother of child, was informed, and she has no concerns. The child had no adverse reaction to double dose of Polio.
Information has been received for the Pregnancy Registry for Gardasil from a nurse concerning a 17 year old female patient with sulfonamide allergy (rash) who on 15-JAN-2007 was vaccinated with a first dose of Gardasil.  The nurse reported that the patient completed the Gardasil series was found to be pregnant on 09-AUG-2007 when she was admitted to the emergency room due to a car accident.  Her urine test was positive for pregnancy in the emergency room.  No other details were available.  The outcome was unknown.  Additional information has been requested.
symptoms of bronchitis started on 2/1/2021, 2 days after receiving the moderna vaccine. Tested for COVID-19 as a precaution on 2/3 with an RNA test and positive result.   It is important to note that the patient works for the Department of Public Health and was working vaccine clinics on 1/29 and 1/30 with approximately 600 exposures to staff and patients coming through the clinics. It is very likely it was contracted through this chronic exposure, even though each individual exposure was very short in terms of minutes spent with each patient.
And now her and her husband have COIVD; And now her and her husband have COIVD; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown manufacturer), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 08Jan2022, outcome "unknown" and all described as "And now her and her husband have COIVD". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical information: She states she took the Pfizer COVID-19 vaccine last Apr and was fine after the first dose was okay but after the second dose had a bad reaction 2 days after with heart racing and her right eye had a blood burst. And now her and her husband have COIVD, was diagnosed around 08Jan2022 and their doctor prescribed Paxlovid around the 13th or 14th of Jan2022 and they took it for 5 days and she states she never had high blood pressure in her life and the last 4 days her blood pressure has been like 150 something then 160. It use to be 120/80.  The lot number for bnt162b2 was not provided and will be requested during follow up.
1. Injection Site Muscle Soreness 2. Sensitive Teeth, sensitive to cold or hot beverages.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with an expired dose of ZOSTAVAX (lot # K000328 exp date 06-MAR-2015). No adverse effects were reported. Additional information has been requested.
Starting one day after my vaccine, i began to feel a clogging and muffled sensation in my right ear. Slowly throughout the day i lost my hearing in that ear. I also have difficulty breathing through my nose, especially my right nostril.
1-2 hours after getting Pneumovax pt. experienced soreness up & down arm & neck, began to itch.  Pt woke at 4AM w/ fever symptoms (chilled & shakes) but no temp taken.  Upon recommendation of RPH applied ice & resolving after 3 days later.  Now itches like healing sore up and down arm.  Hurts to scratch but no loss of functionability.
This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen under armpit), PAIN (soreness/pain) and PYREXIA (fever) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 3014M20A and 030120A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced PERIPHERAL SWELLING (swollen under armpit), PAIN (soreness/pain) and PYREXIA (fever). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swollen under armpit), PAIN (soreness/pain) and PYREXIA (fever) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported not being on any concomitant medications.
Covid Arm: swelling and pain from injection site to elbow. Arm 50% bigger  in size due to swelling.  Red. Painful. Hot.  Pain under the arm at the armpit.
Patient complained of tingling in her jaw and severe headache within minutes of vaccine injection. There were no apparent signs of reaction such as rash or swelling.
Headache, Myalgia, Arthralgia, Fever, soreness at injection site Narrative: